{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T21:25:39Z","timestamp":1789248339996,"version":"build-2803163510"},"reference-count":90,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.arcmed.2023.102920","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:46:03Z","timestamp":1700837163000},"page":"102920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Genetic Testing in Hereditary Pituitary Tumors"],"prefix":"10.1016","volume":"54","author":[{"given":"Gamze","family":"Akku\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-9432","authenticated-orcid":false,"given":"M\u00e1rta","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2023.102920_bib0001","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: a systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0002","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1210\/jc.2006-1668","article-title":"High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium","volume":"91","author":"Daly","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0003","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11060-013-1354-5","article-title":"Epidemiology and etiopathogenesis of pituitary adenomas","volume":"117","author":"Aflorei","year":"2014","journal-title":"J Neurooncol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0004","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-17-0796","article-title":"European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas","volume":"178","author":"Raverot","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2020.100242","article-title":"Malignancy course of pituitary adenoma in MEN1 syndrome: Clinical-Neuroradiological signs","volume":"7","author":"Incandela","year":"2020","journal-title":"Eur J Radiol Open"},{"key":"10.1016\/j.arcmed.2023.102920_bib0006","doi-asserted-by":"crossref","first-page":"e2247","DOI":"10.1210\/clinem\/dgaa040","article-title":"Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors","volume":"105","author":"Marques","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0007","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s12022-017-9474-7","article-title":"Pituitary carcinoma in a patient with an SDHB mutation","volume":"28","author":"Tufton","year":"2017","journal-title":"Endocr Pathol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0008","first-page":"256","article-title":"Invasive ACTH-producing pituitary gland neoplasm secondary to MSH2 mutation","author":"Loughrey","year":"2021","journal-title":"Cancer Genet"},{"key":"10.1016\/j.arcmed.2023.102920_bib0009","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/330566a0","article-title":"Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas","volume":"330","author":"Vallar","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.arcmed.2023.102920_bib0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2023.102920_bib0011","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-020-16052-8","article-title":"Somatic SF3B1 hotspot mutation in prolactinomas","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.arcmed.2023.102920_bib0012","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1210\/endrev\/bnaa006","article-title":"Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms","volume":"41","author":"Srirangam Nadhamuni","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2023.102920_bib0013","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1126\/science.1126100","article-title":"Pituitary adenoma predisposition caused by germline mutations in the AIP gene","volume":"312","author":"Vierimaa","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.arcmed.2023.102920_bib0014","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/humu.21292","article-title":"Characterization of aryl hydrocarbon receptor interacting protein (AIP) mutations in familial isolated pituitary adenoma families","volume":"31","author":"Igreja","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.arcmed.2023.102920_bib0015","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1210\/jc.2017-01045","article-title":"Fatal Carney Complex in siblings due to de novo large gene deletion","volume":"102","author":"Stelmachowska-Banas","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0016","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/er.2012-1013","article-title":"Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene","volume":"34","author":"Beckers","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/j.arcmed.2023.102920_bib0017","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/jc.2007-2611","article-title":"The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas","volume":"93","author":"Leontiou","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0018","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/JOE-11-0054","article-title":"AIP and its interacting partners","volume":"210","author":"Trivellin","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0019","doi-asserted-by":"crossref","first-page":"9177","DOI":"10.18632\/oncotarget.24183","article-title":"Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland","volume":"9","author":"Hernandez-Ramirez","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.arcmed.2023.102920_bib0020","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.celrep.2019.04.014","article-title":"Aryl hydrocarbon receptor interacting protein maintains germinal center B cells through suppression of BCL6 degradation","volume":"27","author":"Sun","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.arcmed.2023.102920_bib0021","doi-asserted-by":"crossref","DOI":"10.1038\/s41416-022-01964-7","article-title":"AIP: A double agent? The tissue-specific role of AIP as a tumour suppressor or as an oncogene","author":"Haworth","year":"2022","journal-title":"Br J Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0022","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/onc.2014.50","article-title":"AIP inactivation leads to pituitary tumorigenesis through defective Galphai-cAMP signaling","volume":"34","author":"Tuominen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2023.102920_bib0023","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2012-1111","article-title":"Somatostatin analogs modulate AIP in somatotroph adenomas: the role of the ZAC1 pathway","volume":"97","author":"Chahal","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0024","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1038\/s41388-021-02009-8","article-title":"RET signalling provides tumorigenic mechanism and tissue specificity for AIP-related somatotrophinomas","volume":"40","author":"Garcia-Rendueles","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.arcmed.2023.102920_bib0025","unstructured":"Stiles CE, Korbonits M. Familial Isolated Pituitary Adenoma. In: Feingold KR, Anawalt B, Boyce A, Chrousos G, de Herder WW, Dhatariya K, Dungan K, Grossman A, Hershman JM, Hofland J, Kalra S, Kaltsas G, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrere B, McGee EA, McLachlan R, Morley JE, New M, Purnell J, Sahay R, Singer F, Stratakis CA, Trence DL, Wilson DP, eds. Endotext. South Dartmouth (MA) 2020. Chapter pp. 11\u201311. http:\/\/www.endotext.org\/neuroendo\/neuroendo11a11\/neuroendo11a11.htm."},{"key":"10.1016\/j.arcmed.2023.102920_bib0026","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/EC-19-0004","article-title":"AIP-mutated acromegaly resistant to first-generation somatostatin analogs: long-term control with pasireotide LAR in two patients","volume":"8","author":"Daly","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.arcmed.2023.102920_bib0027","article-title":"Low aryl hydrocarbon receptor-interacting protein expression is a better marker of invasiveness in somatotropinomas than Ki-67 and p53","author":"Pinho","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.arcmed.2023.102920_bib0028","doi-asserted-by":"crossref","unstructured":"Loughrey PB, Korbonits M. Genetics of Pituitary Tumours. In: Igaz P, Patocs A, eds. Genetics of Endocrine Diseases and Syndromes. Cham: Springer 2019;111:171\u2013211.","DOI":"10.1007\/978-3-030-25905-1_10"},{"key":"10.1016\/j.arcmed.2023.102920_bib0029","doi-asserted-by":"crossref","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","article-title":"Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers","volume":"100","author":"Hernandez-Ramirez","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0030","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/jmedgenet-2017-104957","article-title":"Risk category system to identify pituitary adenoma patients with AIP mutations","volume":"55","author":"Caimari","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.arcmed.2023.102920_bib0031","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.2012.04445.x","article-title":"Familial pituitary adenomas - Who should be tested for AIP mutations?","volume":"77","author":"Korbonits","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102920_bib0032","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1210\/jc.2019-00432","article-title":"Surgery, octreotide, temozolomide, bevacizumab, radiotherapy, and pegvisomant treatment of an AIP mutation positive child","volume":"104","author":"Dutta","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0033","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2023.102920_bib0034","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","article-title":"Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study","volume":"4","author":"Iacovazzo","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.arcmed.2023.102920_bib0035","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/EJE-15-1044","article-title":"Very low frequency of germline GPR101 genetic variation and no biallelic defects with AIP in a large cohort of patients with sporadic pituitary adenomas","volume":"174","author":"Lecoq","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0036","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI131609","article-title":"GPR101 mediates the pro-resolving actions of RvD5n-3 DPA in arthritis and infections","volume":"130","author":"Flak","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arcmed.2023.102920_bib0037","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/ERC-15-0038","article-title":"X-linked acrogigantism syndrome: clinical profile and therapeutic responses","volume":"22","author":"Beckers","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0038","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1530\/JOE-18-0446","article-title":"Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects","volume":"240","author":"Pepe","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0039","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13059-016-1110-1","article-title":"New insights into the generation and role of de novo mutations in health and disease","volume":"17","author":"Acuna-Hidalgo","year":"2016","journal-title":"Genome Biol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/ERC-15-0478","article-title":"GHRH excess and blockade in X-LAG syndrome","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0041","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2015-4366","article-title":"Somatic GPR101 duplication causing X-linked acrogigantism (XLAG)-diagnosis and management","volume":"101","author":"Rodd","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0042","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1210\/jc.2019-00817","article-title":"Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother","volume":"104","author":"Wise-Oringer","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0043","series-title":"Paper presented at: Genetics in Medicine","article-title":"De novo prenatal diagnosis of X-linked Acromegaly Gigantism (X-LAG)","author":"Dunnington","year":"2022"},{"key":"10.1016\/j.arcmed.2023.102920_bib0044","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/ERC-16-0082","article-title":"Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0045","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1530\/ERC-17-0131","article-title":"Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease","volume":"24","author":"Hernandez-Ramirez","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0046","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2015-3324","article-title":"The Cables1 Gene in Glucocorticoid Regulation of Pituitary Corticotrope Growth and Cushing Disease","volume":"101","author":"Roussel-Gervais","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0047","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.ajhg.2017.03.011","article-title":"Germline Mutations in CDH23, Encoding Cadherin-Related 23, Are Associated with Both Familial and Sporadic Pituitary Adenomas","volume":"100","author":"Zhang","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.arcmed.2023.102920_bib0048","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/83667","article-title":"Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D","volume":"27","author":"Bolz","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2023.102920_bib0049","doi-asserted-by":"crossref","first-page":"T119","DOI":"10.1530\/ERC-17-0199","article-title":"The future: genetics advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"Agarwal","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verges","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0051","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0052","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 study group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0053","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cancergen.2015.12.002","article-title":"Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine years","volume":"209","author":"Concolino","year":"2016","journal-title":"Cancer Genet"},{"key":"10.1016\/j.arcmed.2023.102920_bib0054","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0055","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2008-2083","article-title":"Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states","volume":"94","author":"Agarwal","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0056","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/cen.14706","article-title":"Molecular genetic testing in the management of pituitary disease","volume":"97","author":"Coopmans","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.arcmed.2023.102920_bib0057","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.arcmed.2023.102920_bib0058","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2023.102920_bib0059","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0060","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/js.2017-00231","article-title":"Corticotropinoma as a Component of Carney Complex","volume":"1","author":"Hernandez-Ramirez","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.arcmed.2023.102920_bib0061","doi-asserted-by":"crossref","first-page":"K7","DOI":"10.1530\/EJE-17-0227","article-title":"PRKAR1A mutation causing pituitary-dependent Cushing disease in a patient with Carney complex","volume":"177","author":"Kiefer","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0062","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.arcmed.2023.102920_bib0063","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: an update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0064","doi-asserted-by":"crossref","first-page":"E183","DOI":"10.1210\/jc.2013-3159","article-title":"Deletions of the PRKAR1A locus at 17q24.2\u2013q24.3 in Carney complex: genotype-phenotype correlations and implications for genetic testing","volume":"99","author":"Salpea","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0065","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMc1309730","article-title":"PRKACB and Carney complex","volume":"370","author":"Forlino","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2023.102920_bib0066","doi-asserted-by":"crossref","first-page":"E531","DOI":"10.1210\/jc.2014-3399","article-title":"Heterogeneous genetic background of the association of pheochromocytoma\/paraganglioma and pituitary adenoma - results from a large patient cohort","volume":"100","author":"D\u00e9nes","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0067","doi-asserted-by":"crossref","first-page":"R157","DOI":"10.1530\/ERC-22-0157","article-title":"Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours","volume":"29","author":"Loughrey","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0068","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case Report of a Prolactinoma in a Patient With a Novel MAX Mutation and Bilateral Pheochromocytomas","volume":"1","author":"Roszko","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.arcmed.2023.102920_bib0069","doi-asserted-by":"crossref","first-page":"L37","DOI":"10.1530\/ERC-18-0065","article-title":"Pheochromocytomas and pituitary adenomas in three patients with MAX exon deletions","volume":"25","author":"Daly","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.arcmed.2023.102920_bib0070","doi-asserted-by":"crossref","unstructured":"Pozza C, Sesti F, Di Dato C, et al. A Novel MAX Gene Mutation Variant in a Patient With Multiple and \u201cComposite\u201d Neuroendocrine-Neuroblastic Tumors. Front Endocrinol (Lausanne) 2020;11:234. doi:10.3389\/fendo.2020.00234.","DOI":"10.3389\/fendo.2020.00234"},{"key":"10.1016\/j.arcmed.2023.102920_bib0071","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple Endocrine Tumors Associated with Germline MAX Mutations: Multiple Endocrine Neoplasia Type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0072","first-page":"18","article-title":"A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma","volume":"2018","author":"Maher","year":"2018","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.arcmed.2023.102920_bib0073","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1158\/1078-0432.CCR-17-3089","article-title":"DICER1 and Associated Conditions: Identification of At-risk Individuals and Recommended Surveillance Strategies","volume":"24","author":"Schultz","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.arcmed.2023.102920_bib0074","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","article-title":"Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations","volume":"128","author":"de Kock","year":"2014","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0075","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/clinem\/dgaa857","article-title":"Clinical Outcomes and Complications of Pituitary Blastoma","volume":"106","author":"Liu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0076","author":"Doros","year":"2020","journal-title":"DICER1-Related Disorders"},{"key":"10.1016\/j.arcmed.2023.102920_bib0077","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jc.2013-3826","article-title":"Acromegaly and McCune-Albright syndrome","volume":"99","author":"Salenave","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0078","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpeds.2018.09.070","article-title":"Using Digital Droplet Polymerase Chain Reaction to Detect the Mosaic GNAS Mutations in Whole Blood DNA or Circulating Cell-Free DNA in Fibrous Dysplasia and McCune-Albright Syndrome","volume":"205","author":"Romanet","year":"2019","journal-title":"J Pediatr"},{"key":"10.1016\/j.arcmed.2023.102920_bib0079","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1210\/jc.2017-01401","article-title":"Corticotroph Pituitary Carcinoma in a Patient With Lynch Syndrome (LS) and Pituitary Tumors in a Nationwide LS Cohort","volume":"102","author":"Bengtsson","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0080","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1507\/endocrj.EJ17-0036","article-title":"Atypical pituitary adenoma with MEN1 somatic mutation associated with abnormalities of DNA mismatch repair genes; MLH1 germline mutation and MSH6 somatic mutation","volume":"64","author":"Uraki","year":"2017","journal-title":"Endocr J"},{"key":"10.1016\/j.arcmed.2023.102920_bib0081","first-page":"1","article-title":"Aggressive pituitary adenoma in the context of Lynch syndrome: a case report and literature review on this rare coincidence","author":"Teuber","year":"2021","journal-title":"Br J Neurosurg"},{"key":"10.1016\/j.arcmed.2023.102920_bib0082","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1002\/ajmg.a.38308","article-title":"Growth hormone excess in children with neurofibromatosis type-1 and optic glioma","volume":"173","author":"Cambiaso","year":"2017","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.arcmed.2023.102920_bib0083","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41436-018-0312-1","article-title":"Growth hormone excess in neurofibromatosis 1","volume":"21","author":"Hannah-Shmouni","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.arcmed.2023.102920_bib0084","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvac083","article-title":"Ockham's Razor for a Retinal Lesion and Acromegaly and Breaking the Vicious Circle","volume":"6","author":"Rak-Makowska","year":"2022","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.arcmed.2023.102920_bib0085","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10014-007-0220-6","article-title":"Hyperprolactinemia and immunohistochemical expression of intracellular prolactin and prolactin receptor in primary central nervous system tumors and their relationship with cellular replication","volume":"24","author":"Soares Leaes","year":"2007","journal-title":"Brain Tumor Pathol"},{"key":"10.1016\/j.arcmed.2023.102920_bib0086","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/ng.2453","article-title":"Loss-of-function mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular enlargement","volume":"44","author":"Sun","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.arcmed.2023.102920_bib0087","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1210\/jc.2015-3880","article-title":"IGSF1 Deficiency: Lessons From an Extensive Case Series and Recommendations for Clinical Management","volume":"101","author":"Joustra","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0088","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1210\/clinem\/dgz093","article-title":"IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction","volume":"105","author":"Joustra","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.arcmed.2023.102920_bib0089","doi-asserted-by":"crossref","unstructured":"Costa MM, Korbonits M. Genetic causes of familial pituitary tumors. In: Caplan M, ed. Reference Module in Biomedical Research. Elsevier 2017;2:185\u2013211.","DOI":"10.1016\/B978-0-12-801238-3.64199-5"},{"key":"10.1016\/j.arcmed.2023.102920_bib0090","doi-asserted-by":"crossref","DOI":"10.1007\/s12020-023-03497-2","article-title":"Multiple endocrine neoplasia type 4 (MEN4): a thorough update on the latest and least known men syndrome","author":"Ruggeri","year":"2023","journal-title":"Endocrine"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440923001583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:15:05Z","timestamp":1741184105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440923001583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":90,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0188440923001583"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102920","relation":{},"ISSN":["0188-4409"],"issn-type":[{"value":"0188-4409","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic Testing in Hereditary Pituitary Tumors","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2023.102920","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102920"}}